Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis
Noble is a pulmonologist at Cedars-Sinai iand chief of its lung institute. Frohna is the chief medical officer of Endeavor BioMedicines, a company developing therapies for fibrotic disease and cancer. Their wide-ranging discussion of idiopathic pulmonary …